PPAR-Gamma agonist rosiglitazone is neuroprotective after stroke in type II diabetic rodents

被引：0
|
作者：
Vemuganti, R. [1 ]
Tureyen, K. [1 ]
Satriotomo, I. [1 ]
Bowen, K. [1 ]
Kapadia, R. [1 ]
Feinstein, D. [2 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Univ Illinois, Dept Anesthesiol, Chicago, IL USA
来源：
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2009年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S253 / S253
页数：1
相关论文
共 50 条
  • [11] PPAR-gamma gene expression is elevated in skeletal muscle of obese and Type II diabetic subjects
    Park, KS
    Ciaraldi, TP
    AbramsCarter, L
    Mudaliar, S
    Nikoulina, SE
    Henry, RR
    DIABETES, 1997, 46 (07) : 1230 - 1234
  • [12] Lipid profile and glucose tolerance during intervention with rosiglitazone, a PPAR-gamma agonist, in Brazilian obese subjects
    Barroso, SG
    Duarte, SFP
    Sanjuliani, AF
    Rodrigues, MLG
    Valença, DC
    Genelhu-Abreu, V
    Pimentel, MMG
    Francischetti, EA
    JOURNAL OF HYPERTENSION, 2004, 22 : S85 - S85
  • [13] A placebo-controlled trial of the insulin-sensitizing PPAR-gamma agonist rosiglitazone in patients with AD
    Craft, S
    Watson, GS
    Asthana, S
    Chapman, D
    Reger, M
    Baker, LD
    Hyde, K
    Cholerton, B
    Plymate, S
    Kahn, S
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S91 - S91
  • [14] PPAR-gamma activation is neuroprotective after TBI by preventing inflammation and oxidative stress
    Yi, John
    Brooks, Nathaniel
    Park, Seung-Won
    Dharap, Ashutosh
    Vemuganti, Raghu
    JOURNAL OF NEUROTRAUMA, 2008, 25 (07) : 912 - 912
  • [15] Angiotensin II, PPAR-gamma and atherosclerosis
    Kintscher, U
    Lyon, CJ
    Law, RE
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 359 - 369
  • [16] ADIPONECTIN MEDIATES THE BENEFICIAL EFFECT OF PPARγ AGONIST ROSIGLITAZONE ON ENDOTHELIAL FUNCTION IN TYPE II DIABETIC MICE
    Tian, Xiao Yu
    Wong, Wing Tak
    Hoo, R. L.
    Xu, Aimin
    Vanhoutte, Paul
    Huang, Yu
    JOURNAL OF VASCULAR RESEARCH, 2009, 46 : 66 - 66
  • [17] The role of the synthetic PPAR-gamma rosiglitazone ligand in the pathogenetic treatment of type 2 diabetes mellitus
    Kononenko, I., V
    Smirnova, O. M.
    DIABETES MELLITUS, 2005, 8 (02): : 66 - 73
  • [18] The PPAR-gamma agonist, pioglitazone, reverses neuropathic pain behavior in the obese Zucker Diabetic Fatty Rat
    Donahue, Renee Rivas
    Garrett, Colleen
    Taylor, Bradley
    FASEB JOURNAL, 2009, 23
  • [19] Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
    Kapadia, Ramya
    Yi, Jae-Hyuk
    Vemuganti, Raghu
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 1813 - 1826
  • [20] Rosiglitazone, a PPAR-gamma agonist, does not alter the pharmacokinetics of nifedipine, a cytochrome P450 3A4-substrate
    Freed, MI
    Miller, AK
    Inglis, AM
    Thompson, KA
    Ladley, D
    Jorkasky, DK
    DIABETES, 1998, 47 : A94 - A94
12345